Edition:
United Kingdom

Ajanta Pharma Ltd (AJPH.NS)

AJPH.NS on National Stock Exchange of India

963.20INR
11:10am BST
Change (% chg)

Rs14.95 (+1.58%)
Prev Close
Rs948.25
Open
Rs951.00
Day's High
Rs967.00
Day's Low
Rs931.00
Volume
92,246
Avg. Vol
314,743
52-wk High
Rs1,294.00
52-wk Low
Rs825.00

Latest Key Developments (Source: Significant Developments)

India's Ajanta Pharma June-Qtr Consol PAT Rises
Wednesday, 31 Jul 2019 

July 31 (Reuters) - Ajanta Pharma Ltd ::JUNE QUARTER CONSOL PAT 1.15 BILLION RUPEES VERSUS 1.06 BILLION RUPEES YEAR AGO.JUNE QUARTER CONSOL REVENUE FROM OPERATIONS 6.12 BILLION RUPEES VERSUS 5.11 BILLION RUPEES YEAR AGO.  Full Article

India's Ajanta Pharma March-Qtr Consol Profit Falls
Tuesday, 30 Apr 2019 

April 30 (Reuters) - Ajanta Pharma Ltd ::MARCH QUARTER CONSOL PROFIT 888.9 MILLION RUPEES VERSUS PROFIT 944.9 MILLION RUPEES YEAR AGO.MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 5.15 BILLION RUPEES VERSUS 5.30 BILLION RUPEES YEAR AGO.  Full Article

India's Ajanta Pharma Sept-Qtr Profit Falls
Wednesday, 31 Oct 2018 

Oct 31 (Reuters) - Ajanta Pharma Ltd ::SEPT QUARTER CONSOL PROFIT 1.25 BILLION RUPEES VERSUS 1.32 BILLION RUPEES YEAR AGO.SEPT QTR CONSOL REVENUE FROM OPS 5.44 BLN RUPEES VS 5.40 BLN RUPEES YR AGO.  Full Article

India's Ajanta Pharma June Quarter Consol PAT Rises
Tuesday, 31 Jul 2018 

July 31 (Reuters) - Ajanta Pharma Ltd ::JUNE QUARTER CONSOL PAT 1.06 BILLION RUPEES VERSUS PAT OF 947.9 MILLION RUPEES YEAR AGO.JUNE QUARTER REVENUE FROM OPERATIONS 5.11 BILLION RUPEES VERSUS 4.73 BILLION RUPEES YEAR AGO.  Full Article

Ajanta Pharma Says No Form 483 Issued By USFDA To Facility At Dahej
Friday, 9 Feb 2018 

Feb 9 (Reuters) - Ajanta Pharma Ltd ::SAYS FORMULATION FACILITY AT DAHEJ WAS INSPECTED BY US FDA FROM 5TH TO 9TH FEBRUARY.SAYS NO FORM 483 WAS ISSUED TO CO.  Full Article

Ajanta Pharma's Vice-Chairman​ Purushottam B. Agrawal Resigns
Friday, 15 Dec 2017 

Dec 15 (Reuters) - Ajanta Pharma Ltd ::SAYS ‍ PURUSHOTTAM B. AGRAWAL RESIGNS AS VICE-CHAIRMAN​.  Full Article

India's Ajanta Pharma Sept-qtr consol profit rises marginally
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Ajanta Pharma Ltd ::Sept quarter consol net profit 1.32 billion rupees versus 1.31 billion rupees year ago.Sept quarter consol revenue from operations 5.40 billion rupees versus 5.16 billion rupees year ago.  Full Article